Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: Report from the PTLD.Int survey

Annals of Transplantation

Volumn 15, Issue 4, 2010, Pages 102-109

  Izadi, Morteza ^a   Taheri, Saeed ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Dr Taheri Medical Research Group   (Iran)

Author keywords

EBER; EBV encoded RNA; In situ hybridization; Post transplant lymphoproliferative disorders; Ptld

Indexed keywords

UNTRANSLATED RNA;

ALLOGRAFT; ARTICLE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; SURVIVAL RATE; TREATMENT OUTCOME;

B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISORDERS; ORGAN TRANSPLANTATION; RNA, VIRAL; SURVIVAL RATE;

EID: 78651262919     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Craig FE, Gulley ML, Banks PM: Post-transplantation lymphoproliferative disorders. Am J Clin Pathol, 1993; 99: 265-276
2. Hoffman H, Schlette E, Actor J, Medeiros LJ: Pleural post-transplantation lymphoproliferative disorders following liver transplantation. Arch Pathol Lab Med, 2001; 125(3): 419-423
3. Pourfarziani V, Taheri S, Lessan-Pezeshki M et al: Lymphoma after living donor kidney transplantation: an Iranian multicenter experience. Int Urol Nephrol, 2008; 40(4): 1089-1094
4. Khedmat H, Taheri S: Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant, 2009; 14(4): 80-85
5. Khedmat H, Taheri S: Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant, 2009; 14(3): 74-77
6. Hanto DW, Gajl-Peczalska KJ, Frizzera G et al: Epstein- Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg, 1983; 198: 356-369
7. Pitchenik AE, Fischl MA, Walls KW: Evaluation of cerebral-mass lesions in acquired immunodeficiency syndrome. N Engl J Med, 1983; 308: 1099
8. Shapiro R, Nalesnik M, McCauley J et al: Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus- based immunosuppression. Transplantation, 1999; 68: 1851
9. Khedmat H, Alavian SM, Taheri S: Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders. Ann Transplant, 2010; 15(2): 40-44
10. Kieff E, Rickinson AB: Epstein-Barr virus and its replication. In Knipe DM, Howley PM, Griffin DE et al: (eds.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa, 2001; 2511-2573
11. Diehl V, Henle G, Henle W, Kohn G: Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol, 1968; 2: 663-669
12. Pope JH, Horne MK, Scott W: Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer, 1968; 3: 857-866
13. Yajima M, Kanda T, Takada K: Critical role of Epstein- Barr Virus (EBV)-encoded RNA in efficient EBV- induced B-lymphocyte growth transformation. J Virol, 2005; 79(7): 4298-4307
14. Komano J, Maruo S, Kurozumi K et al: Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol, 1999; 73: 9827-9831
15. Ruf IK, Rhyne PW, Yang C et al: Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol, 2000; 74: 10223-10228
16. Wood BL, Sabath D, Broudy VC, Raghu G: The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients. A report of three cases. Cancer, 1996; 78(10): 2223-2228
17. Abe T, Ichimaru N, Kokado Y et al: Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years. Int J Urol, 2010; 17(1): 48-54
18. Niedobitek G, Mutimer DJ, Williams A et al: Epstein- Barr virus infection and malignant lymphomas in liver transplant recipients. Int J Cancer, 1997; 73(4): 514-520
19. Vilchez RA, Jauregui MP, Hsi ED et al: Simian virus 40 in posttransplant lymphoproliferative isorders. Hum Pathol. 2006; 37(9): 1130-1136
20. Sarkar S, Selvaggi G, Mittal N et al: Gastrointestinal tract ulcers in pediatric intestinal transplantation patients: etiology and management. Pediatr Transplant, 2006; 10(2): 162-167
21. Pitman SD, Huang Q, Zuppan CW et al: Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomor phic B-cell PTLD both clinically and pathologically. Am J Surg Pathol, 2006; 30(4): 470-476
22. Gheorghe G, Albano EA, Porter CC et al: Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature. J Pediatr Hematol Oncol, 2007; 29(2): 112-16
23. Craig FE, Gulley ML, Banks PM: Posttransplantation lymphoproliferative disorders. Am J Clin Pathol, 1993; 99: 265
24. Wu JF, Ho MC, Ni YH et al: Timing of Epstein-Barr virus acquisition and the course of osttransplantation lymphoproliferative disorder in children. Transplantation. 2009; 87(5): 758-762
25. Manlhiot C, Pollock-Barziv SM, Holmes C et al: Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients. J Heart Lung Transplant, 2010; 29(6): 648-657
26. Timms JM, Bell A, Flavell JR et al: Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet, 2003; 361(9353): 217-223
27. Sebelin-Wulf K, Nguyen TD, Oertel S et al: Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. Transpl Immunol, 2007; 17(3): 203-210
28. Ganne V, Siddiqi N, Kamaplath B et al: Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for posttransplant lymphoproliferative disorder. Clin Transplant, 2003; 17: 417
29. Sevmis S, Pehlivan S, Shabazov R et al: Posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Transplant Proc, 2009; 41(7): 2881-2883
30. Collins MH, Montone KT, Leahey AM et al: Posttransplant lymphoproliferative disease in children. Pediatr Transplant, 2001; 5: 250-257
31. Buadi FK, Heyman MR, Gocke CD et al: Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study. Am J Hematol, 2007; 82(3): 208-214
32. Kerkar N, Morotti RA, Madan RP et al: The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring. Pediatr Transplant, 2010; 14(4): 504-511
33. Djokic M, Le Beau MM, Swinnen LJ et al: Posttransplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities. Genes Chromosomes Cancer, 2006; 45(3): 313-318
34. Dusenbery D, Nalesnik MA, Locker J, Swerdlow SH: Cytologic features of post-transplant ymphoproliferative disorder. Diagn Cytopathol, 1997; 16(6): 489-496
35. Sevilla DW, Weeden EM, Alexander S et al: Nodular pattern of bone marrow infiltration: frequent finding in immunosuppression-related EBV-associated large B-cell lymphomas. 1. Virchows Arch, 2009; 455(4): 323-336
36. Hézode C, Duvoux C, Germanidis G et al: Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology, 1999; 30(3): 775-778
37. Rohr JC, Wagner HJ, Lauten M et al: Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatr Transplant, 2008; 12(4): 426-431
38. Norin S, Kimby E, Ericzon BG et al: Posttransplant lymphoma - a single-center experience of 500 liver transplantations. Med Oncol, 2004; 21(3): 273-284
39. Capello D, Cerri M, Muti G et al: Molecular histogenesis of posttransplantation lymphoproliferative disorders. Blood, 2003; 102: 3775-3785
40. Castellano-Sanchez AA, Li S et al: Primary central nervous system post-transplant lymphoproliferative disorders. Am J Clin Pathol, 2004; 121: 246-253
41. Jain AB, Marcos A, Pokharna R et al: Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation, 2005; 80(12): 1692-1698
42. Mamzer-Bruneel MF, Lomé C, Morelon E et al: Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center. J Clin Oncol, 2000; 18(21): 3622-3632
43. Khedmat H, Taheri S: Characteristics and Prognosis of Post Transplantation Lymphoproliferative Disorders within Renal Allograft: Report from PTLDint Survey. Ann Transplant, 2010; (Accepted)
44. Alavian SM, Izadi M, Zare AA et al: Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists. Spec Care Dentist, 2008; 28(6): 265-270
45. Pourfarziani V, Ramezani MB, Taheri S et al: Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: a comparative controlled trial. Ann Transplant, 2008; 13(3): 43-47
46. Jonaidi Jafari N, Ranjbar R, Haghi-Ashtiani MT et al: The study of prevalence and antimicrobial susceptibility of tracheal bacterial strains isolated from pediatric patients. Pak J Biol Sci, 2009; 12(5): 455-458
47. Pourfarziani V, Taheri S, Lessan-Pezeshki M et al: Lymphoma after living donor kidney transplantation: an Iranian multicenter experience. Int Urol Nephrol, 2008; 40(4): 1089-1094
48. Nalesnik M, Jaffe R, Starzl TE et al: The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol, 1988; 133: 173-192
49. Swanson MA, Schwartz RS: Immunosuppressive therapy: the relation between clinical response and immunologic competence. N Engl J Med, 1967; 227: 163
50. Iwatsuki K, Xu Z, Ohtsuka M, Kaneko F: Cutaneous lymphoproliferative disorders associated with Epstein-Barr virus infection: a clinical overview. J Dermatol Sci, 2000; 22: 181-195
51. Hanto DW, Frizerra G, Gajl-Peczalska KJ et al: Epstein- Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med, 1982; 306(15): 913-918
52. Aris RM, Maia DM, Neuringer IP et al: Post transplantation lymphoproliferative disorder in the Epstein-Barr nai{dotless}ve lung transplant recipient. Am J Respir Crit Care Med, 1996; 154(6): 1712-1717
53. Walker RC, Marshall WF, Strickler JG et al: Pretransplantation assessment of the risk of ymphoproliferative disorder. Clin Infec Dis, 1995; 20: 1346-1353
54. Sugawara Y, Mizugaki Y, Uchida T et al: Detection of Epstein-Barr virus (EBV) in hepatocellular arcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology, 1999; 256: 196-202
55. Bonnet M, Guinebretiere JM, Kremmer E et al: Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst, 1999; 91: 1376-1381
56. Yao Y, Minter HA, Chen X et al: Heterogeneity of HLA and EBER expression in Epstein-Barr irusassociated nasopharyngeal carcinoma. Int J Cancer, 2000; 88: 949-955
57. Greifenegger N, Jager M, Kunz-Schughart LA et al: Epstein-Barr virus small RNA (EBER) genes: differential regulation during lytic viral replication. J Virol, 1998; 72: 9323-9328
58. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N: Epstein-Barr virus small nuclear RNAs are not Expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA, 1990; 87: 8790-8794
59. Wen S, Shimizu N, Yoshiyama H et al: Association of Epstein-Barr virus (EBV) with Sjogren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am J Pathol, 1996; 149: 1511-1517
60. Wen S, Mizugaki Y, Shinozaki F, Takada K: Epstein- Barr virus (EBV) infection in salivary gland tumors: lytic EBV infection in nonmalignant epithelial cells surrounded by EBV positive T-lymphoma cells. Virology, 1997; 227: 484-487
61. Mizugaki Y, Sugawara Y, Shinozaki F, Takada K: Detection of Epstein-Barr virus in oral papilloma. Jpn J Cancer Res, 1998; 89: 604-607